The Handoff: Your Weekly Neurology News Roundup

Share this content:

The Handoff is a weekly roundup of neurology news covering various developments in subspecialties, as well as pharmaceutical and association and society news. Keep your finger on the pulse of neurology with The Handoff.

- The American Heart Association/ American Stroke Association has released a policy statement addressing the early implementation of palliative care in patients with advanced cardiovascular disease and stroke.

- The French health ministry is denying any wrongdoing after a weekly newspaper claimed that over 10,000 pregnant women were given Sanofi's antiepileptic drug depakine despite well-known risks of fetus malformation and neurodevelopmental disabilities.

- The first patients have been dosed with Zynerba Pharmaceuticals' ZYN002 cannabidiol gel in the Phase 2 STAR 1 clinical trial. The drug is the first and only synthetic, transdermal CBD formulation being developed for the treatment of refractory focal seizures.

- Eisai and Biogen are moving on to Phase 3 trials of their BACE inhibitor treatment for Alzheimer's disease after the FDA deemed their Phase 2 data "sufficient." The new trial will measure the effect of 50 mg/day of E2609 in Alzheimer's patients after previous data indicated that treatment decreased beta-amyloid levels in plasma and CSF in a dose-dependent fashion.

- Mayo Clinic in Rochester, Minn. claimed the top spot on US News & World Report's best hospitals for neurology and neurosurgery for the third year in a row, scoring an overall 100 out of 100. Johns Hopkins and New York-Presbyterian followed at second and third.

- A workshop at Northwestern University is helping people with dementia and their partners cope with changes through storytelling.

- A robotic suit that bridges the brain-machine interface has allowed for partial neurological recovery in patients with severe spinal cord injuries. Watch the video below for more about the groundbreaking technology.

Video courtesy Nature Publishing Group

You must be a registered member of Neurology Advisor to post a comment.

Next Article in The Handoff

Sign Up for Free e-newsletters

CME Focus